Phase III Trial of Autologous Bone Marrow Stem Cell Transplantation with a Three-Dimensional Woven-Fabric Scaffold for Periodontitis

Abstract EN

Regenerative medicine is emerging as a promising option, but the potential of autologous stem cells has not been investigated well in clinical settings of periodontal treatment.

In this clinical study, we evaluated the safety and efficacy of a new regenerative therapy based on the surgical implantation of autologous mesenchymal stem cells (MSCs) with a biodegradable three-dimensional (3D) woven-fabric composite scaffold and platelet-rich plasma (PRP).

Ten patients with periodontitis, who required a surgical procedure for intrabony defects, were enrolled in phase I/II trial.

Once MSCs were implanted in each periodontal intrabony defect, the patients were monitored during 36 months for a medical exam including laboratory tests of blood and urine samples, changes in clinical attachment level, pocket depth, and linear bone growth (LBG).

All three parameters improved significantly during the entire follow-up period (p<0.0001), leading to an average LBG of 4.7 mm after 36 months.

Clinical mobility measured by Periotest showed a decreasing trend after the surgery.

No clinical safety problems attributable to the investigational MSCs were identified.

This clinical trial suggests that the stem cell therapy using MSCs-PRP/3D woven-fabric composite scaffold may constitute a novel safe and effective regenerative treatment option for periodontitis.